Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Black-Scholes Option Pricing Model

The assumptions used for the Black-Scholes option pricing model to determine the fair value of Base Options granted are as follows:

	December 31,
	2024		2023		2022
Risk-free interest rate	4.45% -4.65%		3.43% - 4.37%		1.94% - 4.18%
Expected dividends	$	—	$	—	$	—
Expected volatility	59.25% -59.43%		55.42% - 65.04%		48.66% - 64.29%
Expected term (in years)	6.25		6.25		6.25

Schedule of Option Activity

The Company’s outstanding Base Options consisted of the following (shares in thousands):

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Stock options outstanding as of January 1, 2024	9,430	$	8.23
Granted	2,536	4.61
Exercised	(1,287)	1.63
Forfeited	(1,516)	13.48
Stock options outstanding as of December 31, 2024	9,163	$	7.29	5.9	$	1,193
Expected to vest as of December 31, 2024	3,159	$	8.73	8.4	$	—
Exercisable as of December 31, 2024	6,004	$	6.53	4.7	$	1,193

The Company’s outstanding Upside Options consisted of the following (shares in thousands):

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Stock options outstanding as of January 1, 2024	7,826	$	7.31
Exercised	(221)	3.00
Forfeited	(643)	14.84
Stock options outstanding as of December 31, 2024	6,962	$	6.75	3.6	$	—
Expected to vest as of December 31, 2024	572	$	10.54	5.4	$	—
Exercisable as of December 31, 2024	6,390	$	6.41	3.4	$	—

Schedule of Restricted Stock and Performance Shares

The following table summarizes employee restricted stock award activity, including performance stock units, for the year ended December 31, 2024 (units in thousands):

	Restricted Stock Units	Weighted-Average Grant-Date Fair Value
Unvested as of January 1, 2024	2,982	$	24.39
Granted	11,416	4.68
Vested	(1,067)	23.67
Forfeited	(2,259)	9.73
Unvested as of December 31, 2024	11,072	7.13

The following table summarizes Physician Partners Equity Awards activity, including performance stock units, for the year ended December 31, 2024 (units in thousands):

	Restricted Stock Units	Weighted-Average Grant-Date Fair Value
Unvested as of January 1, 2024	7,137	$	20.39
Granted	2,139	8.65
Vested	(1,382)	21.10
Forfeited	(1,108)	22.39
Unvested as of December 31, 2024	6,786	16.24